Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

NCT00148902 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Breast

Interventions

DRUG: lapatinib
DRUG: docetaxel

Sponsor

GlaxoSmithKline